Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1321959

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1321959

Global Cardioverter Defibrillator Device Market Size, Share, Growth Analysis, By Type(implantable cardioverter defibrillators, external cardioverter defibrillators), By End use(hospitals, pre-hospital) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 224 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Cardioverter Defibrillator Device market size was valued at USD 11.19 billion in 2021 and is poised to grow to USD 20.8 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).

The global market for cardioverter defibrillator devices is witnessing steady growth, driven by the rising prevalence of cardiovascular diseases worldwide. These devices play a crucial role in the prevention of sudden cardiac arrests by detecting irregular heart rhythms and delivering electric shocks to restore normal heartbeats. Technological advancements and increasing awareness about early diagnosis and treatment options are further fueling market expansion. The growing demand for implantable cardioverter defibrillators (ICDs) and external defibrillators indicate a promising future for the global cardioverter defibrillator device market.

Top-down and bottom-up approaches were used to estimate and validate the size of Cardioverter Defibrillator Device and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Cardioverter Defibrillator Device market is segmented based on the Products, Technology, End User and region. Based on the Products, the Cardioverter Defibrillator Device market is segmented into software and services. Based on the technology, the Cardioverter Defibrillator Device Market has been segmented into Web based software, Cloud based software. Based on end users Cardioverter Defibrillator Device Market is segmented into Hospitals, Clinics, Ambulatory Surgery Centre, Diagnostic Centres and Others. Based on Region Cardioverter Defibrillator Device Market is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

Defibrillators have made significant advancements in terms of cost reduction, size reduction, and ease of use. The technological progress includes the development of automated external defibrillators (AEDs) and implantable cardioverter defibrillators (ICDs). These devices are highly effective in managing cardiac conditions. With the advancements in defibrillator technology, operating the device has become simpler for trained individuals.

Restrain

The cost of cardioverter defibrillators poses a significant barrier, particularly for patients from low-income backgrounds. Additionally, limited healthcare budgets may result in a lower adoption rate of these devices in the future.

Trend

A smart pacemaker is an innovative device capable of detecting even the slightest irregularities in heart function. It addresses abnormalities in the heart and restores normal bodily functions. Furthermore, it provides alerts to both patients and physicians regarding the patient's cardiac health. This feature of the smart pacemaker contributes to reducing mortality rates.

Product Code: SQMIG35A2207

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Cardioverter Defibrillator Device Market by Type
    • Market Overview
    • implantable cardioverter defibrillators
    • external cardioverter defibrillators
  • Global Cardioverter Defibrillator Device Market by End use
    • Market Overview
    • hospitals
    • pre-hospital
    • public access market
    • alternative care
    • home
  • Global Cardioverter Defibrillator Device Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Biotronik SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Microport Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Nihon Kohden Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Progetti Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Schiller AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Zoll Medical Corporation (a subsidiary of Asahi Kasei Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Defibtech, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cardiac Science Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Physio-Control International (a subsidiary of Stryker Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CU Medical Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Fukuda Denshi Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mindray Medical International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Welch Allyn, Inc. (a subsidiary of Hill-Rom Holdings, Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cardionet (a subsidiary of BioTelemetry, Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!